In the recent article, “Theranos’s Alleged Tampering with Data is Almost Unheard Of in BioTech, Say Experts,” Fast Company reported on recent accusations that Theranos, a biotech company that aims to make it possible to run blood tests from the prick of a finger rather than a needle injected into a vein, tampered with its data to make its technology appear more accurate. Representatives for Theranos deny that the alleged incident occurred. In the article, Professor Patricia Zettler explained,”FDA takes data tampering very seriously, and there are a number of things that FDA might do if a company or researcher submitted false data to the agency.”
Patricia J. Zettler is an associate professor at Georgia State University College of Law and a member of the Center for Law, Health & Society. She was a former attorney with the Food and Drug Administration. Zettler’s research focuses on the regulation of medicine, biotechnology, and biomedical research, as well as food and drug policy.